Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Nature Biotechnology|April 8, 2009
Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteinsBernd Wollscheid, Damaris Bausch-Fluck, Christine Henderson, et al.Clinical Proteomics|April 28, 2022
Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancerSandra Goetze, Peter Schüffler, Alcibiade Athanasiou, et al.BJUI Compass|April 27, 2022
Development and validation of a novel multivariate risk score to guide biopsy decision for the diagnosis of clinically significant prostate cancerHelmut Klocker, Bruno Golding, Stephan Weber, et al.European Urology|July 12, 2011
Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteomeMartin Kälin, Igor Cima, Ralph Schiess, et al.Plos One|August 3, 2017
Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancerKathrin Endt, Jens Goepfert, Aurelius Omlin, et al.The Prostate|August 16, 2022
New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health indexDaniela Terracciano, Evelina La Civita, Alcibiade Athanasiou, et al.Journal of Proteome Research|December 14, 2011
Comprehensive description of the N-glycoproteome of mouse pancreatic β-cells and human isletsCarsten Danzer, Katrin Eckhardt, Alexander Schmidt, et al.Cancers|May 13, 2026
The Prognostic Value of Proclarix in Prostate Cancer Patients Under Active Surveillance: Predicting Transition to Active Treatment and Disease Progression in a Danish CohortAlcibiade Athanasiou, Torben F Hansen, Jonna S Madsen, et al.European Urology|January 14, 2014
Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09)Christian Rothermundt, Stefanie Hayoz, Arnoud J Templeton, et al.Current Biology : CB|August 7, 2012
A DNA-damage selective role for BRCA1 E3 ligase in claspin ubiquitylation, CHK1 activation, and DNA repairKo Sato, Elayanambi Sundaramoorthy, Eeson Rajendra, et al.Pageof 4